The places where cancer mortality rates are the highest.
Biosimilars hold great cost savings promises for payers and patients alike—but only if prescribers and patients are willing to make the switch.
Good leaders don’t just rely on one managerial style—they get the best out of every team member by meeting their needs.
Cancer medication spending is unsustainable, but significant savings can be achieved just by reducing waste. Here’s how.
Specialty pharmaceuticals make up a huge part of the current drug market, and their impact is only going to grow over the next few years.
How can payers cope with new, ultra-expensive therapies?
Decades of research has led to a flurry of new warnings.